School of Medicine
Showing 101-200 of 342 Results
-
Laren Becker
Assistant Professor of Medicine (Gastroenterology)
BioI am a physician-scientist in the Division of Gastroenterology at Stanford University. My clinical and research interest has been in neurogastroenterology. Specifically, my research has been exploring the interplay between immune cells and the enteric nervous system, and evaluating how perturbations of this interaction as a result of aging disrupts gastrointestinal neuromuscular function. Ultimately, my hope is that insights from this research provide novel therapies for treating patients with motility disorders like constipation and irritable bowel syndrome.
-
Harmeet Bedi
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Harmeet Bedi is the Director of Interventional Pulmonology & Bronchoscopy at Stanford University. His expertise is in minimally invasive techniques used in the diagnosis and treatment of various airway and lung diseases such as lung cancer, benign & malignant airway obstruction, and pleural diseases. He specializes in rigid & flexible bronchoscopy, robotic bronchoscopy, airway stent placement, balloon bronchoplasty, endobronchial ultrasound (EBUS), and various pleural procedures. He also specializes in a variety of tumor ablative therapies including laser therapy, electrocautery, argon plasma coagulation (APC), brachytherapy, and cryotherapy.
He founded the cone-beam computed tomography (CBCT) - guided bronchoscopy program at Stanford in 2019. CBCT-guided bronchoscopy is a novel and cutting-edge technique which combines bronchoscopy with CT imaging, allowing for improved localization and diagnosis of peripheral lung nodules. Additionally, CBCT-guided bronchoscopy will allow for numerous potential cancer therapies that are currently under development.
Dr. Bedi is a principal investigator and co-investigator on multiple clinical trials related to bronchoscopy, thoracic imaging, pulmonary nodules, and lung cancer. Specifically, he has multiple research interests within the realm of bronchoscopic device innovation and CBCT-guided bronchoscopy. -
Andrew Beel
Instructor, Structural Biology
BioAndrew Beel received an M.D. and a Ph.D. in Biophysics from Stanford, where he studied the structure and condensation of the eukaryotic chromosome under the supervision of Roger Kornberg. He started his independent research program in late 2022 after receiving an Early Independence Award from the Office of the Director of the National Institutes of Health. His group is broadly interested in mesoscale biological organization and the physical underpinnings thereof, with a current emphasis on the axial core of the metaphase chromosome. The Beel lab is actively recruiting new members at all stages of training; interested parties are encouraged to apply (please direct inquiries to beelaj@stanford.edu).
-
Barry Behr, Ph.D., H.C.L.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility), Emeritus
Current Research and Scholarly InterestsDevelopment of improved embryo culture conditions in vitro. Blastocyst cultures. Embryo metabolism in vitro. Embryo maternal dialogue. Clinical application and integration of extended embryo culture systems. Monozygotic twinning. Prevention of multiple pregnancy. Sperm motility enhancers. Fluorescent and non-fluorescent markers of sperm morphology and viablility. Oocyte cryopreservation. Fertility preservation. Improving IVF outcome.
-
Corinne Beinat
Assistant Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsThe focus of my research is to develop novel imaging and treatment strategies to detect and better manage cancer. This approach relies first on the identification and validation of molecular targets and biomarkers that are linked with underlying the underlying biology driving the initiation and progression of cancers. We then develop novel small molecule based radiotracers to monitor fundamental molecular and cellular processes occurring in living subjects using positron emission tomography (PET) with the goal of improving cancer diagnosis and management. We additionally develop novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response. Our overall goal is to develop multiple clinically translatable strategies to improve cancer diagnosis, management, and outcomes.
-
Gill Bejerano
Professor of Developmental Biology, of Computer Science, of Pediatrics (Genetics) and of Biomedical Data Science
Current Research and Scholarly Interests1. Automating monogenic patient diagnosis.
2. The genomic signatures of independent divergent and convergent trait evolution in mammals.
3. The logic of human gene regulation.
4. The reasons for sequence ultraconservation.
5. Cryptogenomics to bridge medical silos.
6. Cryptogenetics to debate social injustice.
7. Managing patient risk using machine learning.
8. Understanding the flow of money in the US healthcare system. -
Benjamin Zewdu Belai
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioBenjamin Belai is a psychiatrist at Stanford Health Care and works specifically in the Centerspace and Evaluation clinics. His focus within these clinics include cultural psychiatry, Black and immigrant mental health, student mental health, and integrated behavioral health. He also works at Roots Community Health Center 2 days a week providing psychiatric consulting services.
-
Sean Bendall
Associate Professor of Pathology
Current Research and Scholarly InterestsOur goal is to understand the mechanisms regulating the development of human systems. Drawing on both pluripotent stem cell biology, hematopoiesis, and immunology, combined with novel high-content single-cell analysis (CyTOF – Mass Cytometry) and imagining (MIBI-Multiplexed Ion Beam Imaging) we are creating templates of ‘normal’ human cellular behavior to both discover novel regulatory events and cell populations as well as understand dysfunctional processes such as cancer.
-
Eran Bendavid
Associate Professor of Medicine (Primary Care and Population Health), of Health Policy, Senior Fellow at the Woods Institute for the Environment and, by courtesy, at the Freeman Spogli Institute for International Studies
Current Research and Scholarly InterestsEffect of global health policies on health of individuals in developing countries, global health, HIV and TB.
-
Edward Bender
Clinical Professor, Cardiothoracic Surgery
BioDr. Edward Bender specializes in the treatment of adult cardiac abnormalities, including ischemic heart disease, structural and valvular disease, and arrhythmias. Additionally, he has an interest and expertise in General Thoracic and Vascular surgery. Dr. Bender currently works with organizations within the medical community to develop software to aid in the teaching and practice of medicine.
-
Peter Bendix, MD, MPH
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Peter Bendix is board-certified in general surgery, trauma surgery, and critical care. He is an assistant professor at the Stanford University School of Medicine. He obtained his medical degree from the University of California – Davis and a master’s degree in public health from the Harvard School of Public Health. He completed surgical residency at Dartmouth and his Acute Care Surgery and Surgical Critical Care fellowships at the Brigham and Women’s Hospital in Boston. His clinical focus is on conditions of traumatic injury, emergency general surgery, and surgical critical care.
Dr. Bendix served in the United States Peace Corps as a health extensionist in The Gambia region of West Africa. He also conducted fieldwork for the National Institutes of Health in Haiti and Mozambique. His research interests include the health impacts of gun violence; and racial, ethnic, and socioeconomic disparities in health care delivery. Prior to joining Stanford, he worked as a trauma surgeon at the University of Chicago. -
Catherine Benedict
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Current Research and Scholarly InterestsMy research focuses on improving cancer survivorship through better understanding of long-term health outcomes and through the development of theoretically driven, evidence-based behavioral interventions to improve adjustment, risk management, and quality of life. To this end, I lead studies aimed to guide and support patient decision-making and self-management after cancer. Much of my work focuses on the experiences of young adults affected by cancer.
-
Anne L Benham
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioI specialize in the assessment and treatment of young children and their families from ages 1-7 years. I focus on understanding of their problems and symptoms from a developmentally informed, family centered , biological and experiential lens that takes into account the child's emotional, behavioral , sociocultural, biological and relationship history. I use attachment theory to understand the psychosocial aspects of the child and his/her history. I provide therapy to children individually and in family dyads or groups as appropriate and always include work with the parents as my collaborators and clients. I have had this focus to my clinical work and teaching of clinicians in training for my career over the past 40 years. I am interested in integrating multiple perspectives to understand and treat families.I use my medical training to work with children who are experiencing medical disorders , trauma, and conditions in the child or in other family members as it impacts the child's sense of self, safety, anxiety and body. I use play to connect with children and to help them communicate their fears, wishes and experiences to augment verbal communication and to process frightening experiences.
-
William Benitz
Philip Sunshine, M.D., Professor in Neonatology, Emeritus
Current Research and Scholarly InterestsNeonatology, patent ductus arteriosus, pulmonary hypertension of the newborn, infant ventilation, neonatal clinical protocols/clinical pathways.
-
Jade Benjamin-Chung
Assistant Professor of Epidemiology and Population Health
Current Research and Scholarly InterestsOur research aims to improve population health by creating high quality evidence about what health interventions work in whom and where, when, and how to implement them. Most of our research is focused on environmentally-mediated infectious diseases, including malaria, diarrhea, soil-transmitted helminths, and influenza. Our focus is on improving the health of vulnerable populations from low-resource settings, both domestically and internationally. We use a variety of epidemiologic, computational, and statistical methods, including causal inference and machine learning methods.
-
Nesrine Benkafadar
Instructor, Otolaryngology (Head and Neck Surgery)
BioDr. Nesrine Benkafadar obtained her Pharm.D from the University of Constantine in Algeria. She then joined the Institute for Neurosciences of Montpellier in France, where she completed a master’s degree in Industrial Pharmacy and obtained her Ph.D in Biology and Health. She mainly worked on establishing a functional interaction between oxidative stress, DNA damage and cochlear cell aging. From there, she conducted postdoctoral research in Dr. Stefan Heller’s lab at Stanford University. Her current research is focused on studying the early regenerative triggers in damaged avian cochlea with the overarching goal to characterize the series of events that trigger and execute cochlear hair cell regeneration. Her ultimate goal is to investigate key trigger genes to induce adult mammalian supporting cells in damaged cochlea to reenter the cell cycle toward hair cell regeneration.
-
Christopher Bennett
Assistant Professor of Emergency Medicine (Adult Clinical/Academic)
BioChristopher Bennett, MD, MSc, MA, is a physician scientist in the Department of Emergency Medicine at Stanford University. He is a fellow of both the American College of Emergency Physicians (FACEP) and the American Academy of Emergency Medicine (FAAEM). His primary research interests are in emergency department based HIV testing and in better understanding American's access to both emergency departments and emergency physician care.
Dr. Bennett completed residency training at Harvard Medical School's program in Emergency Medicine based at Massachusetts General Hospital. Along with his medical degree from The University of North Carolina at Chapel Hill, Bennett holds graduate degrees from both Duke and Stanford. In addition to his formal graduate training, Bennett was previously a Howard Hughes Medical Institute Fellow at Johns Hopkins, a scientist with the Lineberger Comprehensive Cancer Center, and a researcher with the Emergency Medicine Network based at Harvard and Massachusetts General Hospital.
Christopher previously served on the Board of Directors for the Society for Academic Emergency Medicine (SAEM) and the Board of Trustees for the SAEM Foundation. He also previously served on the Massachusetts Medical Society's Committee on Publications which directs the publication and distribution of the New England Journal of Medicine. His research has appeared in journals such as the New England Journal of Medicine, JAMA, and JAMA Surgery. His writing has appeared in The American Journal of Bioethics, STAT News, KevinMD.com, and Forbes. -
Rachel Bensen
Clinical Associate Professor, Pediatrics - Gastroenterology
Current Research and Scholarly InterestsMy research focuses on improving health care delivery systems for children, adolescents and young adults with chronic illness and their families. I have particular interests in the development of chronic disease self-management skills, assessment of patient reported outcomes, the transition from pediatric to adult-oriented health care, and comprehensive programs to support families caring for a child with chronic illness.
-
Jonathan S. Berek, MD, MMSc
Laurie Kraus Lacob Professor
BioLaurie Kraus Lacob Professor
Stanford University School of Medicine
Director, Stanford Women’s Cancer Center
Senior Advisor, Stanford Cancer Institute
Executive Director, Stanford Health Communication Initiative
Director, MedArts Films
Stanford Center for Health Education
Stanford University -
Marc Berenson
Clinical Instructor, Emergency Medicine
BioDr. Berenson was born in the heart of New York City and grew up in the NYC metropolitan area with the notable exception of a three-year stint living in the UK. He has also lived in Washington DC and Roanoke VA. Prior to medical school, Dr. Berenson worked as a Mobile Intensive Care Paramedic for well over a decade, spending a significant portion of his time creating and providing EMS-related education. After completing his Bachelor of Arts in Sociology, he went on to attend Rutgers New Jersey Medical School, graduating with a Distinction in Medical Education. He remained at Rutgers NJMS for residency training, serving as Chief Resident in his final year. In his free time, Dr. Berenson enjoys a spontaneous/random adventure, playing piano, and spending quality time with friends and family.
-
Marc Berg
Clinical Professor, Pediatrics - Critical Care
BioDr. Berg was born and raised in rural Minnesota and has been in academic medicine since 1997. His research interests include CPR performance, pediatric defibrillation science, and education primarily through simulation. He has been a volunteer with the American Heart Association for more than 10 years, leading the Pediatric CPR course (PALS) in 2010. He has served in several administrative positions including Division Chief of Pediatric Critical Care at the University of Arizona, Board Director of the University of Arizona Health Network and Governor-appointed member of the Arizona Medical Board. In his free time he enjoys biking, reading and spending time with his family. He is married with three children and lives in Menlo Park, California.
See his LinkedIn profile here:
https://www.linkedin.com/in/marc-berg-6399934/ -
David Bergman
Associate Professor of Pediatrics (General Pediatrics) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsMy research has involved the use of new technologies to create different types of patient-doctor transactions. I am also interested in how these new transactions impact clinical care processes. Current work includes the evaluation of a patient portal for children with cystic fibrosis, the use of telemedicine to bring asthma experts into the schools and the attitudes of teens and parents about the use of a secure patient portal for teens.
-
Dominique Bergmann
Shirley R. and Leonard W. Ely, Jr. Professor of the School of Humanities and Sciences
Current Research and Scholarly InterestsWe use genetic, genomic and cell biological approaches to study cell fate acquisition, focusing on cases where cell fate is correlated with asymmetric cell division.
-
Michele Berk
Assistant Professor of Psychiatry and Behavior Sciences (Child and Adolescent Psychiatry and Child Development)
Current Research and Scholarly InterestsThe focus of my research is on adolescent suicidal and self-harm behavior. I am currently one of four Principal Investigators of a multisite NIMH-sponsored RCT of DBT for adolescents at high risk for suicide (NCT01528020: Collaborative Adolescent Research on Emotions and Suicide [CARES], PI: Linehan, McCauley, Berk, & Asarnow) aimed at evaluating the efficacy of DBT with adolescents compared to a combined individual and group supportive therapy control condition (IGST).
-
Rebecca A. Bernert, PhD, ABPP, FT
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioI am an Assistant Professor of Psychiatry and Behavioral Sciences and a licensed clinical psychologist in the Stanford University School of Medicine. I am a suicidologist, with subspecialty expertise in clinical trials, epidemiology, and suicide prevention best practices. I have joint specialty in behavioral sleep medicine, treatment development, and thanatology. I am Founding Director of The Stanford Suicide Prevention Research Laboratory, and Co-Chair a number of initiatives to support multidisciplinary efforts in suicide prevention. Our program utilizes cognitive, biological (e.g., fMRI), and behavioral testing paradigms, with an emphasis on translational therapeutics across the lifespan. Our mission is to identify novel therapeutics, including seminal work to establish the subfield of sleep and suicide prevention. A special focus is the development of rapid-action, low-risk interventions for the prevention of suicide. Our mission is to evaluate transdiagnostic risk factors and biomarkers underlying treatment response that may inform etiology, reduce stigma, and advance innovation. Advocating for its utility as a visible, yet non-stigmatizing warning sign of suicide—our earliest work delineated sleep as a risk factor for suicidal behaviors. Funded by NIH and DOD, we subsequently conducted the first suicide prevention clinical trials, testing efficacy of a rapid-action (6 h) insomnia treatment for suicidal behaviors. These use a mechanisms focus to identify central disease processes (eg, underlying neural circuitry, behavioral factors) for anti-suicidal response. An overarching aim is to harness new technologies to aid risk prediction, precision medicine, and intervention opportunity. We are committed to improving national training practices (e.g., national needs-assessment of medical training parameters; AI for suicide prevention), and lead hospital best practices for safety in screening, triage, and postvention.
Regarding translation to policy, I have served as a content expert for nationally-directed health initiatives with NIH, VA, DOD, DARPA, SAMHSA, CDC, and The White House. I recently led development of the CA 2020-25 Statewide Strategy for Suicide Prevention, following invited testimony (CA State Assembly) and a commissioned Policy Brief on suicide prevention best practices. Advisory and advocacy work centers on how research guides public health policy and implementation. I am especially committed to initiatives promising impact to suicide prevention on a broad scale, including universal strategies for lethal means restriction and real-time surveillance of suicidal behaviors. To this end, I have been honored to serve as a content expert to The White House Office of Science and Technology for initiatives focused on technology innovation and led advisory work promoting suicide deterrent systems for private organizations and public sites, such as the Golden Gate Bridge. I have consulted for technology companies, as well as private industry and healthcare partners.
Inspired by maternity leaves coinciding with the above work, I have a separate research line examining organizational development, inclusive practices, sleep and employee wellness. This addresses disparate impact of institutional and federal medical leave practices on recruitment and retention of women. Our program focuses on cost-effective policy for diversity training and reduced attrition of women in medicine, law, STEM and technology fields. As such, I am dedicated to spearheading development of a Stanford Center for Policy, Inclusive Practices, and Equity Education.
To donate or partner with us, please contact Deborah Stinchfield (Stanford Medical Center Development) medicalgiving@stanford.edu or please contact us directly. -
Daniel Bernstein
Alfred Woodley Salter and Mabel G. Salter Endowed Professor of Pediatrics
Current Research and Scholarly Interests1. Using iPSC-derived cardiomyocytes to understand hypertrophic cardiomyopathy and heart failure associated with congenital heart disease.
2. Role of alterations in mitochondrial dycamics and function in normal physiology and disease.
3. Differences between R and L ventricular responses to stress,
4. Immune biomarkers of risk after pediatric VAD implantation.
5. Biomarkers for post-transplant lymphoproliferative disorder. -
Jon Bernstein
Professor of Pediatrics (Genetics) and, by courtesy, of Genetics
Current Research and Scholarly InterestsMy research is focused on the diagnosis, discovery and delineation of rare genetic conditions with a focus of neurodevelopmental disorders. This work includes the application of novel computational methods and multi-omics profiling (whole genome sequencing, RNA sequencing, metabolomics). I additionally participate in an interdisciplinary project to develop induced pluripotent stem cell (iPSC) models of genetic neurodevelopmental disorders..
-
Wendy J. Bernstein
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioSenior Community Psychiatrist, Wellness Equity Alliance, Medical Director, Project ECHO and Telemedicine for Severe Mental Illness Track to support the Mental Health of SGBV survivors in Democratic Republic of Congo project. Past Associate Medical Director at Casa del Sol, specialty mental health clinic of La Clinica de la Raza in Oakland California from 2013 to July 2021. Previously at Kaiser Permanente, Northern California, from 2000 to 2013, and Contra Costa County Older Adults Clinics from 1995-2000. Graduate of McGill University Faculty of Medicine, Montreal, Canada, and Boston University Psychiatry Residency. Interests include global health, community mental health, Latinx and underserved populations, women's health, and elder care.
-
William Berquist
Professor of Pediatrics (Gastroenterology), Emeritus
Current Research and Scholarly InterestsGastroenterology, gastointestinal motility, clinical management of pediatric liver transplant recipients.
-
Gerald Berry
Richard Kempson, M.D., Professor of Surgical Pathology
Current Research and Scholarly InterestsCardiopulmonary and pulmonary transplant medicine; diagnostic surgical pathology
-
Mark Francis Berry, MD
Mylavarapu Rogers Professor of Cardiothoracic Surgery
BioDr. Berry joined the Division of Thoracic Surgery at Stanford in August 2014. He came to Stanford from Duke University, where he had most recently served as Associate Professor. He received his medical degree at the University of Pennsylvania School of Medicine after receiving bachelors and masters degrees in Electrical Engineering at the University of Pennsylvania. He completed his residency in Cardiothoracic Surgery at Duke University Medical Center after performing a residency in General Surgery at the Hospital of the University of Pennsylvania. His Cardiothoracic Surgical training included a year dedicated to Minimally Invasive General Thoracic Surgery, a period that also included an American Association for Thoracic Surgery sponsored Traveling Fellowship at the University of Pittsburgh.
Dr. Berry practices all aspects of thoracic surgery, including procedures for benign and malignant conditions of the lung, esophagus, and mediastinum. He has a particular interest in minimally invasive techniques, and has extensive experience in treating thoracic surgical conditions using video-assisted thoracoscopic surgical (VATS), laparoscopic, robotic, endoscopic, and bronchoscopic approaches. He serves as the co-Director of the Stanford Minimally Invasive Thoracic Surgery Center (SMITS), and has both directed and taught in several minimally invasive thoracic surgery courses.
Dr. Berry also has a Masters of Health Sciences in Clinical Research from Duke University. His clinical research activities mirror his clinical interests and activities in optimizing short-term and long-term outcomes of patients with thoracic surgical conditions. He has more than 150 peer-reviewed publications, most of which are related to both the use of minimally invasive thoracic surgical techniques as well as evaluating outcomes after treatment of thoracic malignancies. His clinical practice and his research both focus on choosing the most appropriate treatment and approach for patients based on the individual characteristics of the patient and their disease process. -
Edward Bertaccini
Professor of Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly Interestsmolecular modeling of anesthetic-protein interactions, molecular modeling of the ligand-gated ion channels
-
Alice Bertaina MD, PhD
Lorry I. Lokey Professor
On Leave from 03/01/2024 To 04/30/2024Current Research and Scholarly InterestsDr. Bertaina is a highly experienced clinician and will play a key role in supporting Section Chief Dr. Rajni Agarwal and Clinical Staff in the Stem Cell Transplant Unit at Lucile Packard Children’s Hospital. She will also continue her research on immune recovery and miRNA, understanding the mechanisms underlying immune reconstitution, Graft-versus-Host Disease (GvHD), and leukemia relapse after allogeneic HSCT in pediatric patients affected by hematological malignant and non-malignant disorders.
-
Carolyn Bertozzi
Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology
BioProfessor Carolyn Bertozzi's research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface sugars important to human health and disease. Her research group profiles changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and uses this information to develop new diagnostic and therapeutic approaches, most recently in the area of immuno-oncology.
Dr. Bertozzi completed her undergraduate degree in Chemistry at Harvard University and her Ph.D. at UC Berkeley, focusing on the chemical synthesis of oligosaccharide analogs. During postdoctoral work at UC San Francisco, she studied the activity of endothelial oligosaccharides in promoting cell adhesion at sites of inflammation. She joined the UC Berkeley faculty in 1996. A Howard Hughes Medical Institute Investigator since 2000, she came to Stanford University in June 2015, among the first faculty to join the interdisciplinary institute ChEM-H (Chemistry, Engineering & Medicine for Human Health). She is now the Baker Family Director of Stanford ChEM-H.
Named a MacArthur Fellow in 1999, Dr. Bertozzi has received many awards for her dedication to chemistry, and to training a new generation of scientists fluent in both chemistry and biology. She has been elected to the Institute of Medicine, National Academy of Sciences, and American Academy of Arts and Sciences; and received the Lemelson-MIT Prize, the Heinrich Wieland Prize, the ACS Award in Pure Chemistry, and the Chemistry of the Future Solvay Prize, among others.
The Bertozzi Group develops chemical tools to study the glycobiology underlying diseases such as cancer, inflammation, tuberculosis and most recently COVID-19. She is the inventor of "bioorthogonal chemistry", a class of chemical reactions compatible with living systems that enable molecular imaging and drug targeting. Her group also developed new therapeutic modalities for targeted degradation of extracellular biomolecules, such as antibody-enzyme conjugates and Lysosome Targeting Chimeras (LYTACs). As well, her group studies NGly1 deficiency, a rare genetic disease characterized by loss of the human N-glycanase.
Several of the technologies developed in the Bertozzi lab have been adapted for commercial use. Actively engaged with several biotechnology start-ups, Dr. Bertozzi cofounded Redwood Bioscience, Enable Biosciences, Palleon Pharmaceuticals, InterVenn Bio, OliLux Bio, Grace Science LLC and Lycia Therapeutics. She is also a member of the Board of Directors of Lilly. -
Allison Betof Warner, MD, PhD
Assistant Professor of Medicine (Oncology)
BioDr. Betof Warner is a board-certified, fellowship-trained medical oncologist with the Cutaneous Oncology Program and an Assistant Professor in the Department of Medicine, Division of Medical Oncology. She also serves as Director of Melanoma Medical Oncology, Director of Solid Tumor Cellular Therapy, and co-Director of the Pigmented Lesion and Melanoma Program.
Clinical interests of Dr. Betof Warner include treatment of advanced melanoma, immunotherapy, and cellular therapies for solid tumors. She has been a pioneer in the use of commercial tumor infiltrating lymphocyte (TIL) therapy, which is expected to become standard of care for immunotherapy-refractory melanoma.
Dr. Betof Warner serves as the leader of the Melanoma & Cutaneous Oncology Clinical Research Group, with research interests focused on tumor response to immunotherapy. She has been the principal investigator of multiple clinical trials focusing on immunotherapy-refractory melanoma and is internationally recognized for her expertise in central nervous system metastases and the use of novel cellular therapies. Dr. Betof Warner collaborates with investigators around the world in surgery, neuro-oncology, neurosurgery, radiation oncology, and pathology. She has received funding and awards for her clinical and translational investigative work from multiple high-profile organizations, including the American Society of Clinical Oncology (ASCO), National Institutes of Health (NIH), and Melanoma Research Foundation.
In addition to publishing her research in peer-reviewed journals, Dr. Betof Warner has served as an editorial and grant reviewer for multiple organizations, including the Melanoma Research Foundation. She has authored book chapters and case reports, contributed to national guidelines, and presented her findings at regional, national, and international meetings.
Dr. Betof Warner is a member of multiple professional organizations and societies, including the American Association for Cancer Research, the American Society of Clinical Oncology, and the Society for Immunotherapy of Cancer, where she serves on the Early Career Scientist Committee. She is also a member of the American College of Sports Medicine and the European Society for Medical Oncology. -
Jill Beyer, OD
Clinical Assistant Professor, Ophthalmology
BioJill Beyer, OD, is a Clinical Assistant Professor at Stanford University School of Medicine.
Dr. Beyer graduated from Southern California College of Optometry, earning her Doctor of Optometry degree with distinction. She completed her residency at New England College of Optometry in Boston, Massachusetts, and earned a Bachelor of Science degree in Biology from Oregon State University.
Jill’s residency education included time spent at the Boston Foundation for Sight, Massachusetts Eye and Ear Infirmary, Cornea Consultants & Boston Laser Center, and Harvard Vanguard Medical Associates.
After residency training, Jill continued on as a clinical preceptor at the New England College of Optometry while working in private practice in Boston. She then transitioned to full time academic work at the Massachusetts Eye and Ear Infirmary becoming the Director of the Contact Lens Department and an Instructor in Ophthalmology at Harvard Medical School. -
Gala Beykin, MD
Clinical Instructor, Ophthalmology
BioDr. Beykin is an ophthalmologist and glaucoma specialist at the Byers Eye Institute at Stanford Health Care. She is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Beykin completed clinical and surgical training in glaucoma at the Byers Eye Institute. She specializes in caring for patients with all types of ophthalmic conditions, including glaucoma and cataract.
She has expertise in clinical trial design and implementation, and studies novel biomarkers and candidate therapeutics for vision protection and restoration in glaucoma. Her research efforts include numerous clinical trials investigating new therapies for eye conditions. Dr. Beykin has participated in multiple studies evaluating drugs targeting retinal disease such as AMD and diabetes-related vision loss, as well as ongoing clinical trials assessing new treatment strategies for neuroprotection, neuroregeneration and neuroenhancement in glaucoma. These include implants that could potentially stop or slow the progression of and help improve vision.
Dr. Beykin has published her work in numerous peer-reviewed journals, including the British Journal of Ophthalmology and Investigative Ophthalmology & Visual Science. She has presented her work at national and international meetings, including those for the International Symposium on Retinal Degeneration and the Association for Research in Vision and Ophthalmology.
She is a member of the Israeli Ophthalmology Society, the Israeli Society for Eye and Vision Research, and the Association for Research in Vision and Ophthalmology. -
Joydeep Bhadury
Instructor, Institute for Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsMy goal is to generate universally transplantable human organs in research animals.
-
Vivek Bhalla, MD
Associate Professor of Medicine (Nephrology)
On Partial Leave from 03/01/2024 To 08/31/2024Current Research and Scholarly InterestsDr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.
-
Rashmi Parekh Bhandari
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsClinical interventions, treatments, and outcomes in pediatric pain management
-
Sushma Bharadwaj, MD
Instructor, Medicine - Blood & Marrow Transplantation
BioDr. Bharadwaj is fellowship-trained in blood and marrow transplantation, cellular therapy, hematology, and oncology. She is an instructor in the Stanford School of Medicine Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
Dr. Bharadwaj focuses her expertise on diagnosing and treating cancer in blood and bone marrow. For each patient, she develops a personalized, comprehensive, and compassionate care plan. In her diverse experience as a physician and scientist, she has served as an internal medicine doctor, hospitalist, hematologist, oncologist, and blood and marrow transplantation specialist. Dr. Bharadwaj has a degree in clinical research and is currently conducting clinical trials in transplant and cellular therapy.
She has participated in research studies of advances in therapy for chronic lymphocytic leukemia, melanoma, and breast cancer. She has co-authored articles published in Leukemia and Lymphoma and elsewhere. Topics include advances in cell transplantation. She also co-wrote the chapter on genome-driven personalized cancer therapy in the book Precision Medicine in Oncology.
Dr. Bharadwaj has made presentations at meetings of the American Society of Hematology, American Society of Clinical Oncology, and other associations.
Subjects include racial, demographic, and socioeconomic disparities in the treatment of patients with acute myeloid leukemia.
Dr. Bharadwaj is a member of the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Clinical Oncology. -
Mahendra T. Bhati
Clinical Professor, Psychiatry and Behavioral Sciences
Clinical Professor, NeurosurgeryBioDr. Bhati is an interventional psychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying language abnormalities and transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia. He was a principal investigator for the DSM-5 academic field trials, and his research experiences included roles as an investigator in the first controlled clinical trials of deep brain stimulation (DBS) and low-field synchronized TMS for treatment of depression. His current interests include studying magnetic resonance imaging (MRI) and augmented reality to target TMS, vagus nerve stimulation (VNS) and DBS for treatment-resistant depression, responsive neurostimulation (RNS) for treatment of impulse and fear-related disorders, and focused ultrasound (FUS) for treatment-resistant obsessive compulsive disorder and depression. Dr. Bhati founded and directs a clinical fellowship in Interventional Psychiatry at Stanford.
-
Ami Bhatt
Associate Professor of Medicine (Hematology) and of Genetics
Current Research and Scholarly InterestsThe Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.
-
Apurva Bhatt
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioApurva Bhatt, M.D., is a child, adolescent and adult psychiatrist and Clinical Assistant Professor at Stanford University School of Medicine. Her role spans the General Adult Psychiatry Division, Child Psychiatry Division, and Center for Youth Mental Health and Wellbeing Division.
Dr. Bhatt specializes in early psychosis evaluation and treatment. She currently provides clinical care in both the Lucille Packard Children’s Hospital Child INSPIRE early psychosis clinic and the Stanford Health Care INSPIRE clinic. She contributes to early psychosis program development in California (through EPI-CAL) and nationally (through PEPPNET/Westat). She is also co-chair of the American Academy of Child and Adolescent Psychiatry Adolescent Psychiatry Committee and Early Psychosis work group.
Dr. Bhatt provides school clinical consultations for the Redwood City School District through the Stanford Redwood City Sequoia School Mental Health Collaborative. She also provides clinical consultations to schools in the Los Altos School district, and supervises child and adolescent psychiatry fellows providing consultation to Los Altos, Redwood City, and Mountain View schools.
Dr. Bhatt’s research interests include early psychosis measurement instruments in pediatric populations, Asian American and South Asian youth mental health, and prevention of youth suicide by firearm. She enjoys teaching and mentoring students and trainees, and currently is a mentor through the American Academy of Child and Adolescent Psychiatry and the American Psychiatric Association's FLIPP program. -
Jayanta Bhattacharya
Professor of Health Policy, Senior Fellow at the Stanford Institute for Economic Policy Research, Professor, by courtesy, of Economics and Senior Fellow, by courtesy, at the Freeman Spogli Institute and the Hoover Institution
Current Research and Scholarly InterestsMy research focuses on the constraints that vulnerable populations face in making decisions that affect their health status, as well as the effects of government policies and programs designed to benefit vulnerable populations.
-
Nidhi Bhutani
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsThe long-term goal of our research is to understand the fundamental mechanisms that govern and reprogram cellular fate during development, regeneration and disease.
-
Vinod (Vinny) K. Bhutani
Professor of Pediatrics (Neonatology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsNeonatology; newborn jaundice, bilirubin biology and kernicterus prevention; pulmonary physiology, pulmonary functions and neonatal ventilation. To promote newborn screening for G6PD deficiency in USA.
-
Y. Katherine Bianco
Clinical Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
BioMy clinical interest in pregnancies complicated with birth defects has led my underlying research interests in genomic abnormalities in the human trophoblast carrying to faulty placentation. The latter began with initial work during K12 and KO8 funding. I took a great interest in the human placenta as it carries potential advantages over other tissues sources: first, this highly metabolically active organ is the potential source of many transcripts. Second, the placenta forms at a very early stage of embryonic development, potentially allowing detection of primary alterations as compared to secondary changes that may mask the underlying causal phenomena. Finally, studying early placentation may provide targets for development of novel molecular approaches, such as up-regulate or down-regulate genes, the protein products of which could potentially serve as molecular surrogates for diagnosis and treatment of pregnancy complication such as miscarriages, pre-eclampsia, pregnancy induced hypertension and intrauterine growth retardation. This work has led to the first Trisomy 21, Trisomy 18, trisomy 13 cell lines established from human placentas making it possible to apply gene editing in the early stages of human trophoblast development.
As my primary clinical responsibility involves treating patients needing medical care and support through their high risk pregnancies, I am interested in factors that may impact outcomes, such as prenatal screening and diagnosis, maternal heart conditions, labor and delivery management, and safety approaches for the second stage of labor. In investigating length of labor and approaches to shorten the second stage, I have found methods of improving perinatal outcomes in diverse maternal populations.
With regards to my interest in fetal medicine, I have worked in collaboration with other specialists such as radiologists and pediatric cardiologists utilizing imagining studies to assess and determine successful perinatal care and fetal survival. -
David Bingham
Clinical Assistant Professor, Pathology
BioDavid Bingham MD is a clinical assistant pathologist specializing in gastrointestinal pathology. He is from Connecticut, graduated from Yale with a BA, and went to Columbia P&S for medical school. He did a residency in Pathology at Stanford University, graduated in 1992 and has been here ever since as a faculty member.
-
Michael S Binkley, MD, MS
Assistant Professor of Radiation Oncology (Radiation Therapy)
BioDr. Binkley is a radiation oncologist specializing in lymphoma treatment and an assistant professor in the Stanford University School of Medicine Department of Radiation Oncology.
His clinical expertise includes stereotactic ablative radiotherapy (SABR), total lymphoid and total body irradiation, and intensity modulated radiation therapy (IMRT).
For each patient, Dr. Binkley develops a personalized, comprehensive, and compassionate care plan. His goals are to improve both health and quality of life.
Dr. Binkley has conducted extensive research to advance cancer treatment. In his post-doctoral fellowship at Stanford, he studied the use of genomic signatures to predict response to radiotherapy. His current clinical and laboratory research seek to identify prognostic and predictive clinical, radiographic, and genomic factors to inform individualized treatment strategies.
He has co-authored articles on his research discoveries published in Cancer Discovery, Blood, the International Journal of Radiation Oncology*Biology*Physics, and elsewhere. Topics have included innovations in the treatment of lymphoma and lung cancer.
He also has made invited presentations to colleagues at national and international conferences. He has presented the latest findings on radiation therapy for lung cancer and lymphoma at meetings of the American Society of Clinical Oncology (ASCO), American Society for Radiation Oncology (ASTRO), and International Conference on Malignant Lymphoma (ICML).
Honors for Dr. Binkley include the Malcolm A. Bagshaw Award for leadership and outstanding scientific achievement. This award is named for a pioneer in radiation therapy and former chair of the Departments of Radiology and Radiation Oncology at Stanford University School of Medicine.
Dr. Binkley is a member of the American Society of Clinical Oncology, American Society for Radiation Oncology, and American Association for Cancer Research. He is a founding member of the Global nLPHL One Working (GLOW) Working Group, an international collaboration studying nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in children and adults. -
Julius Bishop, MD
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Bishop specializes in treating fractures of the upper extremity, lower extremity, pelvis and acetabulum as well as the management of post-traumatic problems including malunion, nonunion and infection.
He received his undergraduate and medical school degrees from Harvard University and went on to complete the Harvard Combined Orthopaedic Surgery Residency Program. He pursued his subspecialty training in Orthopaedic Traumatology at the world-renowned Harborview Medical Center in Seattle, Washington.
His research interests include applying decision analysis models to orthopaedic trauma problems, studying clinical outcomes after musculoskeletal injury, orthopaedic biomechanics, the basic science of fracture healing, and evaluating new strategies and techniques in fracture surgery. -
Sandip Biswal, MD
Adjunct Clinical Professor, Radiology
Current Research and Scholarly InterestsThe management of individuals suffering from chronic pain is unfortunately limited by poor diagnostic tests and therapies. Our research group is interested in 'imaging pain' by using novel imaging techniques to study peripheral nociception and inflammation with the goal of accurately identifying the location of pain generators. We are developing new approaches with positron emission tomography (PET) and magnetic resonance imaging (MRI) (PET/MRI) and are currently in clinical trials.
-
Rachelle Bitton
Clinical Assistant Professor, Radiology
Current Research and Scholarly InterestsDeveloping interventional techniques and patient specific models in MR image guided High Intensity Focused Ultrasound (HIFU). PRF thermometry monitoring for ablative applications in cancer trans-cranial functional neurosurgery to treat essential tremor and Parkinson's disease.
Treatment efficacy and clinical outcomes analysis in multi-center trials of MR guided interventions to treat desmoid tumors, uterine leiomyomas, and osseous metastasis.
Photoacoustic imaging of microvasculature. -
Brian Blackburn
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsMy interests include parasitology and global health; I've investigated cryptosporidium and angiostrongylus outbreaks; schistosoma/strongyloides seroprevalence in refugees, and the distribution and impact of ITNs for malaria and filariasis prevention in Nigeria and India. I have done clinical and programmatic work at teaching hospitals in Liberia and Bangladesh and have opportunities for research in Bangladesh and Kenya, in collaboration with ICDDR,B and CDC, Kenya
-
Britney Blair, PsyD, DBSM, CST
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Blair is a licensed clinical psychologist and is board certified in behavioral sleep medicine. Her clinical and research expertise are in behavioral medicine with specializations in sleep and sexual health. She has made numerous presentations, developed workshops, written chapters and published articles in the area of sleep and sexual medicine. Dr. Blair is a Stanford sleep consultant and is on the adjunct faculty at The Stanford Center for Sleep Sciences and Medicine. She is also the Clinical Director of The Clinic.
Dr. Blair completed her postdoctoral fellowship at Stanford University Medical School and her pre-doctoral internship at the VA Greater Los Angeles Health Care System. Dr. Blair received her doctoral degree in Clinical Psychology from the PGSP-Stanford Psy.D. Consortium. She received a bachelor’s degree from the University of California at Berkeley. Prior to beginning her doctoral studies, Dr. Blair founded a successful business consulting firm. -
Richard Bland
Professor (Research) of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsOur research focuses on the pathogenesis and treatment of acute and chronic neonatal lung injury and the mechanisms that regulate lung fluid balance and alveolar & pulmonary vascular development after premature birth.
-
Francis Blankenberg
Associate Professor of Radiology (Pediatric Radiology) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsStudies on apoptotic cell death in vivo using the H MRS phenomenon.
-
Rebecca Blankenburg, MD, MPH
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsMy educational research interests focus on building a more diverse, inclusive and equitable learning environment and helping develop a sense of belonging, professional identity formation, and competence through longitudinal coaching and scholarly mentorship.
-
Terrence Blaschke
Professor of Medicine and of Molecular Pharmacology, Emeritus
Current Research and Scholarly InterestsClinical pharmacology of antiretroviral drugs
Pharmacokinetic and pharmacodynamic mechanisms of variability in drug response.
Drug development -
Helen M. Blau
Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsProf. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.
